Document is current

Article History

Received: 7 March 2018

Accepted: 13 August 2018

First Online: 31 August 2018

Ethics approval and consent to participate

: All the data have already been published in: “Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.” (). This study was approved on July 18, 2008 by the Ethics Committee of Ile de France 1 (“CPP Ile de France 1”) and the French drug administration (AFSSAPS). We used already analysed data and a pre-specified secondary outcome on compliance to antiviral treatment (Trial registration:).

: All the data have already been published in: “Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.” (). This study was approved on July 18, 2008 by the Ethics Committee of Ile de France 1 (“CPP Ile de France 1”) and the French drug administration (AFSSAPS). We used already analysed data and a pre-specified secondary outcome on compliance to antiviral treatment (Trial registration:).

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.